JP2002533326A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002533326A5 JP2002533326A5 JP2000589516A JP2000589516A JP2002533326A5 JP 2002533326 A5 JP2002533326 A5 JP 2002533326A5 JP 2000589516 A JP2000589516 A JP 2000589516A JP 2000589516 A JP2000589516 A JP 2000589516A JP 2002533326 A5 JP2002533326 A5 JP 2002533326A5
- Authority
- JP
- Japan
- Prior art keywords
- amino
- oxy
- phenyl
- acetyl
- propanoic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 *C1OC1N(*)C(*)(*)C(N[C@@](Cc(cc1)ccc1OC1OC1N(*)*)C(O*)=O)=O Chemical compound *C1OC1N(*)C(*)(*)C(N[C@@](Cc(cc1)ccc1OC1OC1N(*)*)C(O*)=O)=O 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9828074.6A GB9828074D0 (en) | 1998-12-18 | 1998-12-18 | Therapeutically useful compounds |
| GB9828074.6 | 1998-12-18 | ||
| PCT/EP1999/010000 WO2000037444A1 (en) | 1998-12-18 | 1999-12-16 | Compounds useful in the treatment of inflammatory diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002533326A JP2002533326A (ja) | 2002-10-08 |
| JP2002533326A5 true JP2002533326A5 (enExample) | 2006-10-19 |
| JP4431282B2 JP4431282B2 (ja) | 2010-03-10 |
Family
ID=10844608
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000589516A Expired - Lifetime JP4431282B2 (ja) | 1998-12-18 | 1999-12-16 | 炎症性疾患の治療に有用な化合物 |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6867192B1 (enExample) |
| EP (1) | EP1140837B1 (enExample) |
| JP (1) | JP4431282B2 (enExample) |
| KR (1) | KR20010101258A (enExample) |
| CN (1) | CN1330637A (enExample) |
| AR (1) | AR023727A1 (enExample) |
| AT (1) | ATE273954T1 (enExample) |
| AU (1) | AU760169B2 (enExample) |
| BR (1) | BR9916282A (enExample) |
| CA (1) | CA2355630A1 (enExample) |
| CO (1) | CO5170533A1 (enExample) |
| CZ (1) | CZ20012209A3 (enExample) |
| DE (1) | DE69919580T2 (enExample) |
| ES (1) | ES2226488T3 (enExample) |
| GB (1) | GB9828074D0 (enExample) |
| GT (1) | GT199900217A (enExample) |
| HK (1) | HK1038744A1 (enExample) |
| HU (1) | HUP0104867A3 (enExample) |
| IL (1) | IL142908A0 (enExample) |
| NO (1) | NO20012995L (enExample) |
| NZ (1) | NZ511478A (enExample) |
| PE (1) | PE20001387A1 (enExample) |
| PL (1) | PL348059A1 (enExample) |
| TR (1) | TR200101709T2 (enExample) |
| WO (1) | WO2000037444A1 (enExample) |
| ZA (1) | ZA200103948B (enExample) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001051487A1 (en) | 1999-12-28 | 2001-07-19 | Pfizer Products Inc. | Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| GB0014881D0 (en) * | 2000-06-16 | 2000-08-09 | Glaxo Group Ltd | Pharmaceutical aerosol formulation |
| GB0014869D0 (en) * | 2000-06-16 | 2000-08-09 | Glaxo Group Ltd | Novel pharmaceutical formulation |
| GB0014892D0 (en) * | 2000-06-16 | 2000-08-09 | Glaxo Group Ltd | Novel pharmaceutical formulation |
| GB0014947D0 (en) * | 2000-06-16 | 2000-08-09 | Glaxo Group Ltd | Novel pharmaceutical formulation |
| GB0014851D0 (en) * | 2000-06-16 | 2000-08-09 | Glaxo Group Ltd | Novel pharmaceutical formulation |
| GB0014849D0 (en) * | 2000-06-16 | 2000-08-09 | Glaxo Group Ltd | Pharmaceutical aerosol formulation |
| GB0014883D0 (en) * | 2000-06-16 | 2000-08-09 | Glaxo Group Ltd | Novel pharmaceutical formulation |
| GB0127423D0 (en) * | 2001-11-15 | 2002-01-09 | Glaxo Group Ltd | Process |
| GB0218630D0 (en) | 2002-08-10 | 2002-09-18 | Tanabe Seiyaku Co | Novel compounds |
| WO2004103967A2 (en) | 2003-05-20 | 2004-12-02 | Genentech, Inc. | Thiocarbamate inhibitors of alpha-4 integrins |
| KR20070029733A (ko) | 2004-06-04 | 2007-03-14 | 제넨테크, 인크. | 다발성 경화증의 치료 방법 |
| US8310442B2 (en) | 2005-02-23 | 2012-11-13 | Pixtronix, Inc. | Circuits for controlling display apparatus |
| US9261694B2 (en) | 2005-02-23 | 2016-02-16 | Pixtronix, Inc. | Display apparatus and methods for manufacture thereof |
| US7999994B2 (en) | 2005-02-23 | 2011-08-16 | Pixtronix, Inc. | Display apparatus and methods for manufacture thereof |
| US8159428B2 (en) | 2005-02-23 | 2012-04-17 | Pixtronix, Inc. | Display methods and apparatus |
| US20070205969A1 (en) | 2005-02-23 | 2007-09-06 | Pixtronix, Incorporated | Direct-view MEMS display devices and methods for generating images thereon |
| US9158106B2 (en) | 2005-02-23 | 2015-10-13 | Pixtronix, Inc. | Display methods and apparatus |
| US8519945B2 (en) | 2006-01-06 | 2013-08-27 | Pixtronix, Inc. | Circuits for controlling display apparatus |
| US9229222B2 (en) | 2005-02-23 | 2016-01-05 | Pixtronix, Inc. | Alignment methods in fluid-filled MEMS displays |
| US8482496B2 (en) | 2006-01-06 | 2013-07-09 | Pixtronix, Inc. | Circuits for controlling MEMS display apparatus on a transparent substrate |
| US7742016B2 (en) | 2005-02-23 | 2010-06-22 | Pixtronix, Incorporated | Display methods and apparatus |
| US9082353B2 (en) | 2010-01-05 | 2015-07-14 | Pixtronix, Inc. | Circuits for controlling display apparatus |
| MY149159A (en) | 2005-11-15 | 2013-07-31 | Hoffmann La Roche | Method for treating joint damage |
| US8526096B2 (en) | 2006-02-23 | 2013-09-03 | Pixtronix, Inc. | Mechanical light modulators with stressed beams |
| US9176318B2 (en) * | 2007-05-18 | 2015-11-03 | Pixtronix, Inc. | Methods for manufacturing fluid-filled MEMS displays |
| TW201438738A (zh) | 2008-09-16 | 2014-10-16 | Genentech Inc | 治療進展型多發性硬化症之方法 |
| US8169679B2 (en) | 2008-10-27 | 2012-05-01 | Pixtronix, Inc. | MEMS anchors |
| WO2010075249A2 (en) | 2008-12-22 | 2010-07-01 | Genentech, Inc. | A method for treating rheumatoid arthritis with b-cell antagonists |
| KR101659642B1 (ko) | 2010-02-02 | 2016-09-26 | 픽스트로닉스 인코포레이티드 | 디스플레이 장치를 제어하기 위한 회로 |
| WO2011097252A2 (en) | 2010-02-02 | 2011-08-11 | Pixtronix, Inc. | Methods for manufacturing cold seal fluid-filled display apparatus |
| WO2013101771A2 (en) | 2011-12-30 | 2013-07-04 | Genentech, Inc. | Compositions and method for treating autoimmune diseases |
| AR091305A1 (es) | 2012-01-31 | 2015-01-28 | Genentech Inc | ANTICUERPOS ANTI-IgE Y SUS METODOS DE USO |
| US9134552B2 (en) | 2013-03-13 | 2015-09-15 | Pixtronix, Inc. | Display apparatus with narrow gap electrostatic actuators |
| WO2015181837A2 (en) * | 2014-05-30 | 2015-12-03 | Sphaera Pharma Pvt. Ltd. | Novel compounds as anti-tubercular agents |
| PL3319639T3 (pl) * | 2015-07-08 | 2021-03-08 | Axerovision, Inc. | Kompozycje farmaceutyczne zawierające antagonistę integryny alfa4 do stosowania w leczeniu stanów zapalnych oka |
| HRP20250052T1 (hr) | 2015-10-06 | 2025-03-14 | F. Hoffmann - La Roche Ag | Postupak liječenja multiple skleroze |
| HRP20220479T1 (hr) * | 2016-06-01 | 2022-05-27 | Athira Pharma, Inc. | Spojevi |
| CN109722455B (zh) * | 2017-10-31 | 2022-03-11 | 中国科学院天津工业生物技术研究所 | 微生物发酵生产谷内酯的方法、工程菌及应用 |
| WO2019246455A1 (en) | 2018-06-20 | 2019-12-26 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an integrin inhibitor |
| ES3003232T3 (en) | 2018-10-30 | 2025-03-10 | Gilead Sciences Inc | Compounds for inhibition of alpha4beta7 integrin |
| ES2987796T3 (es) | 2018-10-30 | 2024-11-18 | Gilead Sciences Inc | Derivados de N-benzoil-fenilalanina como inhibidores de la integrina alfa4beta7 para el tratamiento de enfermedades inflamatorias |
| CN112969687B (zh) | 2018-10-30 | 2024-08-23 | 吉利德科学公司 | 作为α4β7整合素抑制剂的喹啉衍生物 |
| CA3114240C (en) | 2018-10-30 | 2023-09-05 | Gilead Sciences, Inc. | Imidazopyridine derivatives as alpha4beta7 integrin inhibitors |
| CN114222730B (zh) | 2019-08-14 | 2024-09-10 | 吉利德科学公司 | 用于抑制α4β7整合素的化合物 |
| JP2023546915A (ja) * | 2020-10-21 | 2023-11-08 | アズーラ オフサルミックス エルティーディー． | 眼障害を処置するための化合物および方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1593858A1 (de) | 1967-03-02 | 1970-10-29 | Hoechst Ag | Verfahren zur Herstellung tyrosinhaltiger Peptide und deren Derivaten |
| US4105602A (en) | 1975-02-10 | 1978-08-08 | Armour Pharmaceutical Company | Synthesis of peptides with parathyroid hormone activity |
| US6248713B1 (en) | 1995-07-11 | 2001-06-19 | Biogen, Inc. | Cell adhesion inhibitors |
| AU728435B2 (en) | 1997-05-29 | 2001-01-11 | Merck & Co., Inc. | Sulfonamides as cell adhesion inhibitors |
| ES2257808T3 (es) | 1997-05-29 | 2006-08-01 | MERCK & CO., INC. (A NEW JERSEY CORP.) | Acidos biarilalcanoicos como inhibidores de adhesion celular. |
| CA2291778A1 (en) | 1997-05-29 | 1998-12-03 | Merck & Co., Inc. | Heterocyclic amide compounds as cell adhesion inhibitors |
| ATE256699T1 (de) * | 1997-05-30 | 2004-01-15 | Celltech Therapeutics Ltd | Entzündungshemmende tyrosin-derivate |
-
1998
- 1998-12-18 GB GBGB9828074.6A patent/GB9828074D0/en not_active Ceased
-
1999
- 1999-12-15 AR ARP990106429A patent/AR023727A1/es not_active Application Discontinuation
- 1999-12-15 CO CO99078241A patent/CO5170533A1/es not_active Application Discontinuation
- 1999-12-16 AT AT99964583T patent/ATE273954T1/de not_active IP Right Cessation
- 1999-12-16 PL PL99348059A patent/PL348059A1/xx not_active Application Discontinuation
- 1999-12-16 DE DE69919580T patent/DE69919580T2/de not_active Expired - Lifetime
- 1999-12-16 JP JP2000589516A patent/JP4431282B2/ja not_active Expired - Lifetime
- 1999-12-16 TR TR2001/01709T patent/TR200101709T2/xx unknown
- 1999-12-16 EP EP99964583A patent/EP1140837B1/en not_active Expired - Lifetime
- 1999-12-16 IL IL14290899A patent/IL142908A0/xx unknown
- 1999-12-16 ES ES99964583T patent/ES2226488T3/es not_active Expired - Lifetime
- 1999-12-16 HK HK02100145.2A patent/HK1038744A1/zh unknown
- 1999-12-16 PE PE1999001274A patent/PE20001387A1/es not_active Application Discontinuation
- 1999-12-16 CN CN99814654A patent/CN1330637A/zh active Pending
- 1999-12-16 HU HU0104867A patent/HUP0104867A3/hu unknown
- 1999-12-16 NZ NZ511478A patent/NZ511478A/en unknown
- 1999-12-16 CZ CZ20012209A patent/CZ20012209A3/cs unknown
- 1999-12-16 US US09/868,395 patent/US6867192B1/en not_active Expired - Lifetime
- 1999-12-16 KR KR1020017007579A patent/KR20010101258A/ko not_active Withdrawn
- 1999-12-16 BR BR9916282-2A patent/BR9916282A/pt not_active IP Right Cessation
- 1999-12-16 WO PCT/EP1999/010000 patent/WO2000037444A1/en not_active Ceased
- 1999-12-16 CA CA002355630A patent/CA2355630A1/en not_active Abandoned
- 1999-12-16 AU AU30391/00A patent/AU760169B2/en not_active Ceased
- 1999-12-17 GT GT199900217A patent/GT199900217A/es unknown
-
2001
- 2001-05-15 ZA ZA200103948A patent/ZA200103948B/en unknown
- 2001-06-15 NO NO20012995A patent/NO20012995L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002533326A5 (enExample) | ||
| JP2017525757A5 (enExample) | ||
| JP2004538285A5 (enExample) | ||
| US20040192701A1 (en) | Phenlypyridine carbonyl piperazine derivative | |
| JPH10279578A5 (enExample) | ||
| JP2006501295A5 (enExample) | ||
| US20040171619A1 (en) | Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient | |
| JP2008536825A5 (enExample) | ||
| AU2002321669A1 (en) | Novel 2H-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient | |
| JP2004507501A5 (enExample) | ||
| JP2005500370A5 (enExample) | ||
| US20130317041A1 (en) | Compounds | |
| JP2004525892A5 (enExample) | ||
| EP0885218B1 (en) | Oxa- and thia-diazole muscarinic receptor antagonists | |
| JP2003500488A (ja) | 薬理活性を有するスルホンアミド化合物 | |
| PT97510A (pt) | Processo de preparacao de novos derivados da 2-metoxifenilpiperazina | |
| JP2010526801A5 (enExample) | ||
| JP2004506727A5 (enExample) | ||
| JP2003514893A5 (enExample) | ||
| CA2417190A1 (en) | New beta-amyloid inhibitors, processes for preparing them and their use as pharmaceutical compositions | |
| JP2010524863A (ja) | 精神疾患治療用の新規化合物とその調剤及び使用 | |
| CN1711251A (zh) | 4－(苯基－哌嗪基－甲基)苯甲酰胺衍生物及其在治疗疼痛或胃肠疾病中的用途 | |
| JP2006512321A5 (enExample) | ||
| JPH10130212A5 (enExample) | ||
| US20040072865A1 (en) | Aryl piperidine derivatives as inducers of ldl-receptor expression |